The Pre-Market Look: Stocks In The News Before The Open

Quidel (QDEL) dropped over 6% in after-hours trading after it reported preliminary Q4 revenue of $52 million-$53 million, below consensus of $64.1 million.

Stage Stores (SSI) tumbled 10% in after-hours trading after it said comparable store sales fell -7.3% for the 9-week period ending December 31 and then said it sees a 2017 adjusted loss of -70 cents to -85 cents a share, a wider loss than a November 17 estimate of -15 cents to -40 cents.

Coca-Cola (KO) was downgraded to ‘Sell’ from ‘Neutral’ at Goldman Sachs.

VMware (VMW) was downgraded to ‘Neutral’ from ‘Buy’ at UBS.

Dr Pepper Snapple (DPS) was upgraded to ‘Neutral’ from ‘Sell’ at Goldman Sachs with a 12-month target price of $93.

Hormel (HRL) was initiated with an ‘Overweight’ at Piper Jaffray with a 12-month target price of $40.

Teva Pharmaceutical Industries Ltd. (TEVA) was downgraded to ‘Market Perform’ from ‘Outperform’ at Wells Fargo.

Eagle Pharmaceuticals (EGRX) was downgraded to ‘Underperform’ from ‘Neutral’ at Mizuho Securities USA with a 12-month target price of $64.

Ameriprise Financial (AMP) was upgraded to ‘Outperform’ from ‘Neutral’ at Credit Suisse with a price target of $152.

Oasis Petroleum (OAS) was upgraded to ‘Outperform’ from ‘Neutral’ at Macquarie Research with a 12-month target price of $19.

Endologix (ELGX) said a patient death does not appear to be related to its AFX device and that the patient that died experienced a “Type 1B endoleak” which is usually due to natural disease progression. ELGX had fallen over 7% Friday after a FDA report showed the patient’s death may have been due to its AFX system.

Fiat Chrysler Automobiles (FCAU) slid 1% in after-hours trading after it recalled over 86,000 older-model SUVs to replace driver and passenger-side airbags.

Aquinox Pharmaceuticals (AQXP) lost over 1% in after-hours trading after it registered 10.5 million shares for holders.

 

Source: FoxBusiness, Barchart, CNBC, Bloomberg, Reuters